Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients

BACKGROUND: The risk-benefit relationship of memantine treatment for Alzheimer’s disease (AD) remains unclear. In addition, variability between the results of clinical trials has been observed. The aim of this study was to investigate the risk-benefit relationship of memantine treatment in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanco-Silvente, Lídia, Capellà, Dolors, Garre-Olmo, Josep, Vilalta-Franch, Joan, Castells, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057050/
https://www.ncbi.nlm.nih.gov/pubmed/30041625
http://dx.doi.org/10.1186/s12877-018-0857-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057050/
https://www.ncbi.nlm.nih.gov/pubmed/30041625
http://dx.doi.org/10.1186/s12877-018-0857-5

Ejemplares similares